Cinnamaldehyde self-emulsifying nanoemulsion as well as preparation method and application thereof

The cinnamaldehyde nanoemulsion prepared by self-emulsification method of low-energy emulsification method solves the problem of restricted antibacterial application of cinnamaldehyde in the prior art, and realizes the effective removal and steady-state antibacterial effect of MRSA biofilm, which is antibacterial and food Fresh preservation provides new solutions.

CN119015268APending Publication Date: 2024-11-26SICHUAN AGRI UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411115672.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing substances that remove MRSA biofilm have complex preparation, high cost or safety problems, and cinnamaldehyde, as a broad-spectrum antibacterial agent, is limited by its insoluble, highly volatile and irritating odors, resulting in limited antibacterial applications.

Method used

The cinnamaldehyde nanoemulsion was prepared by self-emulsification method. The combination of ethyl acetate, EL-40 and ethanol was used to form an O/W nanoemulsion with an average particle size of (14.29±0.16) nm, which improved the cinnamaldehyde Stability and antibacterial activity.

Benefits of technology

The steady-state and sustained-release antibacterial effects of cinnamaldehyde have been achieved, the removal ability of MRSA biofilm has been enhanced, and a potential antibiotic replacement strategy is provided, and it is suitable for the fields of antibacterial, food preservation and preservation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015268A_ABST
    Figure CN119015268A_ABST
Patent Text Reader

Abstract

The invention discloses cinnamyl aldehyde self-emulsifying nanoemulsion as well as a preparation method and application thereof. The nanoemulsion comprises the following components in percentage by weight: 5-10% of an oil phase, 30-40% of an emulsifier, 15-20% of a co-emulsifier, 5-10% of cinnamyl aldehyde and 20-40% of distilled water. The cinnamyl aldehyde nano-emulsion is prepared by adopting a self-emulsifying method in a low-energy emulsifying method, the preparation method is simple and easier to put into production operation, the drug loading capacity of the nano-emulsion is improved, the energy consumption for preparation is reduced, the preparation efficiency is improved, and the antibacterial application limitation of cinnamyl aldehyde is broken through. The cinnamyl aldehyde nanoemulsion prepared by the method has an average particle size of (14.29 + / -0.16) nm, and has good stability under common conditions. Compared with cinnamyl aldehyde raw medicine, the cinnamyl aldehyde compound has good antibacterial activity and an effect of removing MRSA biofilms.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a cinnamaldehyde self-emulsifying nanoemulsion and a preparation method and application thereof. Background Art

[0002] MRSA (methicillin-resistant Staphylococcus aureus) is a highly resistant bacterium that can resist multiple antibiotics. When MRSA grows in a biofilm, its drug resistance is further enhanced and it is difficult to be eliminated by traditional antimicrobial drugs. Therefore, eliminating MRSA biofilms can help reduce the spread of drug-resistant strains between patients and in medical environments, reducing the risk of infection.

[0003] At present, the commonly used substances for removing MRSA biofilms are bacteriophage lytic enzymes, ferrous sulfate, tea tree essential oil, and anthraquinone compounds. However, bacteriophage lytic enzymes have the disadvantages of complex preparation process and high production cost, ferrous sulfate has the disadvantages of easy oxidation and difficult storage, tea tree essential oil has the disadvantage of high cost, and anthraquinone compounds have safety issues. Therefore, we still need to make breakthroughs in the field of removing MRSA biofilms.

[0004] Cinnamaldehyde (C6H5CH=CHCHO) is a natural phenyl propylene aldehyde compound and the main component of cinnamon essential oil. It is present in large quantities in cinnamon plants. Many studies have shown that it is a broad-spectrum antibacterial agent with good inhibitory effects on Escherichia coli, Salmonella, Staphylococcus aureus and Bacillus. It not only shows a good bactericidal effect, but also effectively inhibits the production of microbial secondary metabolites and is non-toxic and harmless. However, the industrial application of cinnamaldehyde is limited by its own poor solubility, high volatility and the pungent odor emitted as an essential oil. Therefore, its antibacterial application is limited by its relatively low efficacy and large drug dosage. The water solubility of cinnamaldehyde nanoemulsion can be greatly improved by making it into an oil-in-water system, and the stabilization and sustained-release antibacterial synergy of cinnamaldehyde can be further achieved, which is an effective way to broaden the application of cinnamaldehyde as a natural antibacterial agent.

[0005] Nanoemulsion (NE) is a transparent or translucent colloidal dispersion system spontaneously formed by mixing water, oil, surfactant and co-surfactant in appropriate proportions. The droplet diameter is usually less than 100nm, which is both lipophilic and hydrophilic. Due to its small particle size and large specific surface area, it can accelerate the absorption of substances by cells in actual production and application. At the same time, nanoemulsion has a natural advantage in encapsulating volatile oil substances. Water-in-oil nanoemulsion can load water-insoluble volatile oils in the oil phase core, improve the solubility and stability of volatile oils, and protect volatile oils from degradation under external environments such as oxidation, light, enzymatic hydrolysis, acid-base damage, etc. As a nano drug delivery system, the current research on cinnamaldehyde nanoemulsion is still focused on how to achieve the stabilization and sustained release of cinnamaldehyde. Summary of the invention

[0006] The invention aims to provide a cinnamaldehyde self-emulsifying nanoemulsion and a preparation method and application thereof. The nanoemulsion has the function of clearing MRSA biofilm.

[0007] In order to solve the problems existing in the prior art, the technical solution adopted by the present invention is:

[0008] In a first aspect, the present invention provides a cinnamaldehyde self-emulsifying nanoemulsion, wherein the nanoemulsion comprises the following weight percentages: 5-10% oil phase, 30-40% emulsifier, 15-20% co-emulsifier, 5-10% cinnamaldehyde, and 20-40% distilled water.

[0009] Furthermore, the oil phase is ethyl acetate, the emulsifier is EL-40, and the co-emulsifier is ethanol.

[0010] Preferably, the nanoemulsion comprises the following weight percentages: 9.34% ethyl acetate, 39.13% EL-40, 18.2% ethanol, 5% cinnamaldehyde, and 28.33% distilled water.

[0011] Furthermore, the nanoemulsion is an O / W nanoemulsion.

[0012] Furthermore, the average particle size of the nanoemulsion is (14.29±0.16) nm, and the PDI is 0.068±0.003.

[0013] In a second aspect, the present invention provides a method for preparing the cinnamaldehyde self-emulsifying nanoemulsion described in the first aspect, comprising the following steps:

[0014] The oil phase and cinnamaldehyde are put into a stirring device at room temperature, stirred and mixed with a magnetic stirrer, and after a uniform system is formed, the emulsifier and the auxiliary emulsifier are added in sequence and continued to be stirred on the magnetic stirrer. After the system is evenly mixed, the distilled water is continued to be added dropwise while stirring to form a nanoemulsion, and finally a transparent and uniform yellow cinnamaldehyde nanoemulsion system is presented. The cinnamaldehyde self-emulsifying nanoemulsion prepared by the method can effectively improve the stability of cinnamaldehyde and reduce its volatilization rate.

[0015] In a third aspect, the present invention provides use of the cinnamaldehyde self-emulsifying nanoemulsion described in the first aspect in preparing a drug for removing MRSA biofilm.

[0016] In a fourth aspect, the present invention provides a drug for removing MRSA biofilm, comprising the cinnamaldehyde self-emulsifying nanoemulsion described in the first aspect.

[0017] Furthermore, the medicine also includes other pharmaceutically acceptable carriers or excipients.

[0018] The advantages and beneficial effects of the present invention are:

[0019] The invention uses ethyl acetate as the only oil phase of the nanoemulsion drug delivery system, screens surfactants and optimizes prescriptions layer by layer through single factor screening and central point design-response surface optimization method, and adopts the self-emulsification method in the low-energy emulsification method to prepare the cinnamaldehyde nanoemulsion. The preparation method is simple and easier to put into production operation, thereby increasing the drug loading of the nanoemulsion, reducing the preparation energy consumption, and improving the preparation efficiency, thus breaking through the antibacterial application limitation of cinnamaldehyde.

[0020] The cinnamaldehyde nanoemulsion prepared by this method has an average particle size of (14.29±0.16) nm and has good stability under common conditions. Compared with the cinnamaldehyde original drug, it has better antibacterial activity and removal effect on MRSA biofilm. This shows that self-emulsifying cinnamaldehyde nanoemulsion can become a potential strategy for replacing antibiotics in the aquaculture industry. It can also be used in the fields of antibacterial, anti-biofilm, food preservation, and antiseptic. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Comparison of the nanoemulsion area formed by different surfactant systems; where: a is the nanoemulsion area formed by EL-40 and ethanol;

[0022] b is the area of ​​nanoemulsion formed by Tween 80 and ethanol;

[0023] c is the area of ​​nanoemulsion formed by RH-40 and ethanol;

[0024] Figure 2 Comparison of nanoemulsion areas with different Km values; where:

[0025] a is the area of ​​the nanoemulsion formed when Km = 1:1;

[0026] b is the area of ​​the nanoemulsion formed when Km = 2:1;

[0027] c is the area of ​​the nanoemulsion formed when Km = 3:1;

[0028] Figure 3 The three-dimensional effect surface diagram (a) and two-dimensional contour diagram (b) of the influence of X1 and X2 on the average particle size value;

[0029] Figure 4 The three-dimensional effect surface diagram (a) and two-dimensional contour diagram (b) of the effects of X1 and X2 on saturated dosage;

[0030] Figure 5 This is the emulsion type identification result diagram; where:

[0031] a is the static state;

[0032] b is laser pen irradiation;

[0033] c is methylene blue staining;

[0034] d is Sudan red III staining;

[0035] Figure 6 This is the transmission electron microscopy image of cinnamaldehyde self-emulsified nanoemulsion;

[0036] Figure 7 is the particle size distribution of cinnamaldehyde self-emulsifying nanoemulsion;

[0037] Figure 8 is the change of average particle size of cinnamaldehyde self-emulsified nanoemulsion at different pH;

[0038] Fig. 9 is the change of average particle size of cinnamaldehyde self-emulsified nanoemulsion at different temperatures;

[0039] Fig.10 The change of average particle size of cinnamaldehyde self-emulsified nanoemulsion under different light conditions;

[0040] Fig.11 The MIC results of cinnamaldehyde nanoemulsion and cinnamaldehyde original drug against multiple bacterial strains;

[0041] Fig.12 The MBC results of cinnamaldehyde nanoemulsion and cinnamaldehyde original drug against multiple bacterial species;

[0042] Fig.13 Crystal violet staining was performed to clear biofilms in different groups;

[0043] a is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Example 1;

[0044] b is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Example 2;

[0045] c is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 1;

[0046] d is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 2;

[0047] e is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 3;

[0048] f is the cinnamaldehyde group;

[0049] g: PBS group;

[0050] Fig.14 This is a graph showing the effectiveness of nanoemulsion in clearing MRSA biofilm;

[0051] Fig.15 Fluorescence images of live / dead bacteria in biofilms of different groups;

[0052] a is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Example 1;

[0053] b is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Example 2;

[0054] c is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 1;

[0055] d is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 2;

[0056] e is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 3;

[0057] f is the cinnamaldehyde group;

[0058] g: PBS group;

[0059] Fig.16 Fluorescence images of live / dead bacteria in biofilms of different groups;

[0060] a is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Example 1;

[0061] b is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Example 2;

[0062] c is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 1;

[0063] d is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 2;

[0064] e is the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 3;

[0065] f is the cinnamaldehyde group;

[0066] g: PBS group. DETAILED DESCRIPTION

[0067] The following will be combined with the drawings in the embodiments of the present application to clearly describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, rather than all the embodiments. All other embodiments obtained by ordinary technicians in this field based on the embodiments in the present application belong to the scope of protection of this application.

[0068] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0069] Experimental Example 1 Construction of cinnamaldehyde self-emulsifying nanoemulsion drug delivery system

[0070] 1. Preparation method

[0071] This study uses the self-emulsification method in the low-energy emulsification method to prepare cinnamaldehyde nanoemulsion, which overcomes the disadvantage of high energy consumption of the high-energy emulsification method. At the same time, the preparation method is simple and easier to put into production operation. At room temperature, the oil phase and cinnamaldehyde are put into the stirring device in proportion, and stirred and mixed with a magnetic stirrer at 800r / min. After forming a uniform system, the emulsifier and the co-emulsifier are added in proportion, and the stirring is continued on the magnetic stirrer. After the system is mixed evenly, a certain proportion of distilled water is added while stirring to form a nanoemulsion, and finally a transparent and uniform yellow cinnamaldehyde nanoemulsion system is presented.

[0072] 2. Single factor experimental design for nanoemulsion component screening

[0073] 2.1 Oil phase screening:

[0074] Since cinnamaldehyde is a natural phenyl propylene aldehyde compound, it is difficult to dissolve in water, so an organic solvent is selected for dissolution. 10 μL of cinnamaldehyde is dropped into 3 mL of ethyl acetate, oleic acid, and glyceryl monostearate respectively, and stirred on a magnetic stirrer while dropping until the critical saturation state where cinnamaldehyde cannot be dissolved is reached. The amount of cinnamaldehyde added is recorded, and the one with the highest solubility among the three is selected as the oil phase.

[0075] Oil phase screening results:

[0076] By comparing the amount of cinnamaldehyde added by dropping 10 μL of cinnamaldehyde into 3 mL of ethyl acetate, ethyl oleate, and glyceryl monostearate until the critical saturation state where cinnamaldehyde cannot be dissolved, the maximum amount of cinnamaldehyde carried by ethyl acetate, ethyl oleate, and glyceryl monostearate is better, but among the three, ethyl acetate has good fluidity and excellent drug carrying capacity. It is a good solvent that can increase the drug loading capacity of nanoemulsion, so ethyl acetate is selected as the oil phase.

[0077] 2.2 Screening of emulsifiers and co-emulsifiers and determination of Km value:

[0078] The types of emulsifiers and co-emulsifiers and the mass ratio (Km) of emulsifiers and co-emulsifiers in the nanoemulsion drug delivery system were determined by water titration combined with pseudo-ternary phase diagram. The emulsifier and co-emulsifier were mixed at a mass ratio of 3:1, 2:1, 1:1, 1:2, and 1:3, and then the mixed surfactant (Smix) and the oil phase were mixed at a mass ratio of 9:1, 8:2, 7:3, 6:4, 4:6, 3:7, 2:8, 1:9, and 1:1. Distilled water was added dropwise at 800 r / min and (25±1)℃. The critical amount of water added for nanoemulsion demulsification was recorded, and the pseudo-ternary phase diagram was drawn using Origin 2019 to observe the emulsification area. The size of the nanoemulsion area in the pseudo-ternary phase diagram was used as an indicator, and the emulsification ability of the mixed emulsifier (the ability to form nanoemulsions with the oil phase under a certain mass ratio) was combined to determine the formulation composition of the nanoemulsion.

[0079] According to previous studies, three surfactants, Tween 80, polyoxyethylene hydrogenated castor oil (RH-40), and castor oil polyoxyethylene ether EL-40, were combined with emulsifiers ethanol and polyethylene glycol-400 (PEG400) for screening. Since EL40 and PEG400 were stratified after standing, affecting the stability of the nanoemulsion, PEG400 was not selected. Distilled water was added dropwise at 800r / min and (25±1)℃. The critical amount of water added for nanoemulsion demulsification was used, and the pseudo-ternary phase diagram was drawn using Origin 2019 to observe the emulsification area. Figure 1 Taking the area of ​​the nanoemulsion region in the pseudo-ternary phase diagram as an indicator and combining the emulsifying ability of the mixed emulsifier (the ability to form nanoemulsion with the oil phase under certain mass ratio conditions) it was determined that the mixed emulsifier system of the nanoemulsion consisted of EL-40 and ethanol.

[0080] Determination of Km value:

[0081] The mixed surfactant (Smix) and the oil phase were mixed evenly at a mass ratio of 3:1, 2:1, and 1:1, and the Km value of the nanoemulsion was screened using the size of the emulsification area of ​​the pseudo-ternary phase diagram. The purpose of Km screening is to further optimize the formula of the nanoemulsion so that all components can form a stable nanoemulsion when added together regardless of the order. The study found that the Km ratio of surfactant:cosurfactant not only affects the key factors of the emulsification area and position in the phase diagram, but also reduces the free energy of the nanoemulsion system by increasing the dispersion entropy and the interface area, so that the goal of thermodynamic stability of the system can be achieved using a low dose of the auxiliary agent concentration. Figure 2 It shows that compared with other ratios, when Km = 2:1, the emulsion area of ​​the pseudo-ternary phase diagram is the largest, indicating that the nanoemulsion system formed under this condition is more stable. Therefore, Km = 2:1 is tentatively determined.

[0082] 2.3 Nanoemulsion formulation ratio optimization screening star point design-response surface experimental design

[0083] Based on the above experimental results, the oil phase (X1) and Km value (X2) were used as influencing factors, and the particle size (Y1) and saturated dosage (Y2) were used as evaluation indicators. The Design Expert 13.0 software was used to design the experiment using a 2-factor 5-level central point design response surface method, and a regression model was established to determine the optimal preparation process of cinnamaldehyde nanoemulsion. The factors, levels, and experimental arrangements are shown in Table 1.

[0084] Table 1 Factors and levels

[0085]

[0086] The experimental results are shown in Table 2.

[0087] Table 2 CCD-RSM factors, levels and results

[0088]

[0089]

[0090] 2.4 Model Fitting

[0091] After obtaining the experimental results, the model was fitted. The particle size was fitted using the Design Expert13.0 software to obtain a regression equation. The variance analysis regression model was used to determine whether the level of the lack of fit term was significant (P>0.05 was not significant, and p<0.05 was significant). If it was not significant, it indicated that the model fit was good and had good predictive power. At the same time, it was determined whether the model fitting level was significant. If it was significant, it indicated that there were obvious differences between the groups, and different levels of factors had different effects on them. With particle size and drug loading as dependent variables, binomial fitting was performed on each level of each factor to obtain the equation. According to the fitted equation, the Design Expert13.0 software was used to draw a three-dimensional effect surface diagram, and the optimal prescription was predicted by combining the standard that the smaller the average particle size, the better, and the larger the drug loading, the better, and the effect surface diagram.

[0092] In this experimental example, the particle size (Y1) and saturated dosage (Y2) were fitted with a second-order equation using Design Expert 13.0 software to obtain a regression equation.

[0093] Y1=12.89+0.6855X1+0.0913X2+0.4125X1X2+0.5356X1 2 +0.9606X2 2

[0094] (R 2 =0.9742, p<0.0001);

[0095] Y2=0.0116-0.0381X1+0.0030X2(R 2 =0.9522,p<0.0001).

[0096] The particle size model fitting F = 52.94, P < 0.0001 < 0.05, the lack of fit term F = 4.39, P = 0.0933 > 0.05, and the lack of fit term level is not significant, indicating that the model fits well and has good predictive performance. From the above equation, it can be seen that the saturated dosage conforms to the multivariate linear equation, the nonlinear fitting effect of the particle size is good, the correlation coefficients are high, and the results are statistically significant.

[0097] According to the fitted equation, the Design Expert 13.0 software was used to draw a three-dimensional effect surface diagram. The results are as follows: Figure 3 , 4 shown.

[0098] 2.5 Optimal prescription According to the three-dimensional graphs of each effect surface and the equations obtained by model fitting, the prediction function of Design-Expert13.0 was used to obtain the final values ​​of factors X1 and X2, that is, X1 = 14.393%, X2 = 2.151. Combined with the effect surface results and the subsequent actual experiments, the final cinnamaldehyde nanoemulsion prescription was determined, that is, 3g of cinnamaldehyde nanoemulsion contained 0.28g of ethyl acetate, 1.174g of EL-40, 0.546g of ethanol, 0.15g of cinnamaldehyde, and 0.85g of distilled water.

[0099] The component system of cinnamaldehyde self-emulsifying nanoemulsion is obtained by the above method.

[0100] Example 1

[0101] This embodiment provides a cinnamaldehyde self-emulsifying nanoemulsion, wherein the raw materials of the nanoemulsion are: 0.934 g of ethyl acetate, 3.913 g of castor oil polyoxyethylene ether EL-40, 1.82 g of ethanol, 0.5 g of cinnamaldehyde, and 2.833 g of distilled water.

[0102] The present embodiment provides a method for preparing a cinnamaldehyde self-emulsifying nanoemulsion, comprising the following steps: adding ethyl acetate and cinnamaldehyde into a stirring device at 25° C., stirring and mixing with a magnetic stirrer at 800 r / min to form a uniform system, adding EL-40 and ethanol in sequence, and continuing to stir on the magnetic stirrer, and after the system is uniformly mixed, continuing to add distilled water dropwise while stirring to form a nanoemulsion, and finally presenting a transparent and uniform yellow cinnamaldehyde nanoemulsion system.

[0103] Example 2

[0104] This embodiment provides a cinnamaldehyde self-emulsifying nanoemulsion. The raw materials of the nanoemulsion are: 0.5g ethyl acetate, 3g castor oil polyoxyethylene ether EL-40, 1.5g ethanol, 1g cinnamaldehyde, and 4g distilled water. The rest are the same as in Example 1.

[0105] The physicochemical characterization of the cinnamaldehyde self-emulsifying nanoemulsion prepared by the present invention is as follows:

[0106] 1. Emulsion type identification

[0107] Preparation of cinnamaldehyde emulsion:

[0108] At (25±1)℃, 0.467g of ethyl acetate and 1g of cinnamaldehyde were put into a stirring device, stirred and mixed with a magnetic stirrer at 800r / min, and then 1.9565g of EL-40 and 0.91g of ethanol were added in sequence and stirred on the magnetic stirrer to prepare a cinnamaldehyde emulsion.

[0109] Under (25±1)°C, the cinnamaldehyde nanoemulsion, cinnamaldehyde emulsion and distilled water prepared in Example 1 were respectively loaded into 6 vials in equal amounts and divided into two groups, each group comprising bottle A (cinnamaldehyde nanoemulsion), bottle B (cinnamaldehyde emulsion) and bottle C (distilled water). Observe the difference in appearance of the same group, and the cinnamaldehyde nanoemulsion should be a transparent or translucent uniform system.

[0110] In a dark environment, a laser pen was used to shine from one side of the vial to observe the penetration of light in different liquid environments. According to the properties of the nanoemulsion itself, it is a colloidal dispersion system, and the diameter of the emulsion droplets is usually less than 100nm. Therefore, the Tyndall effect will occur after the laser pen rays are shone into it, and a bright path will appear in the solution. However, the emulsion is an emulsion and the blank system is a solution, so no bright path will be formed.

[0111] Equal amounts of water-soluble dye methylene blue and oil-soluble dye Sudan III were added to the two groups respectively, and the diffusion rates of the two in bottles A, B, and C were observed and compared. After meeting the characteristics of the aforementioned nanoemulsion, if the diffusion rate of methylene blue dye in bottle A is greater than that of Sudan dye, it means that the prepared cinnamaldehyde nanoemulsion is an O / W type nanoemulsion.

[0112] Emulsion type identification results:

[0113] like Figure 5 As shown, under the condition of (25±1)℃, bottle A (cinnamaldehyde nanoemulsion) is visually characterized as a transparent light yellow uniform stable liquid, bottle B (cinnamaldehyde emulsion) is a milky white opaque emulsion, and bottle C (blank system without drug loading) is a transparent colorless uniform stable liquid. In a dark environment, a laser pen is used to shine from one side of the vial, and a light path due to the Tyndall effect appears in the liquid of bottle A. According to the properties of the nanoemulsion itself, it is a colloidal dispersion system, and the droplet diameter is usually less than 100nm, so the Tyndall effect will be generated after the laser pen ray is shone into it. In bottles B and C, because the emulsion is an emulsion and the blank system is a solution, no light path is formed.

[0114] The above two groups of phenomena are consistent with the characteristics of nanoemulsions. Equal amounts of water-soluble dye methylene blue and oil-soluble dye Sudan III were added to the two groups, and the diffusion rates of the two in bottles A, B, and C were observed and compared. The diffusion rate of methylene blue dye in bottle A was greater than that of Sudan dye, indicating that the prepared cinnamaldehyde nanoemulsion was an O / W type nanoemulsion.

[0115] In summary, the cinnamaldehyde nanoemulsion prepared by the present invention is an O / W type nanoemulsion.

[0116] 2. Dynamic Light Scattering Characterization

[0117] The cinnamaldehyde nanoemulsion described in Example 1 was divided into three groups, and the particle size and PDI were measured by a nano laser particle size analyzer at 25°C after being diluted 100 times with distilled water. The results are as follows: Figure 7 As shown, the average particle size of cinnamaldehyde is (14.29±0.16) nm, and the PDI is 0.068±0.003. Its particle size is relatively small. The size of the drug will affect its efficiency. Generally, the smaller the size, the easier it is to penetrate the cell membrane, which is beneficial for cinnamaldehyde to enter the bacterial cells and exert its pharmacological effects.

[0118] 3. Morphological Characterization

[0119] The microscopic morphology of the cinnamaldehyde self-emulsifying nanoemulsion described in Example 1 was characterized and observed using a transmission electron microscope (TEM). A small amount of cinnamaldehyde nanoemulsion was dropped onto a copper mesh, dried at room temperature, and then negatively stained with 2% phosphotungstic acid for 10 minutes. The excess dye was removed with filter paper, and after natural drying, the copper mesh was placed under a TEM to observe the microscopic morphology of the preparation and take a photo. The transmission electron microscope results are shown in FIG. Figure 6 As shown, there is no adhesion between the cinnamaldehyde nanoemulsion droplets, which are spherical, round in appearance and smooth on the edges, and the particle size is within 25 nm.

[0120] 4. Stability of cinnamaldehyde self-emulsifying nanoemulsion

[0121] 4.1 Centrifugal stability

[0122] The cinnamaldehyde nanoemulsion of Example 1 was centrifuged at 6000 r / min, 8000 r / min, and 10000 r / min, respectively. There was no stratification of the nanoemulsion before and after centrifugation and no visual changes. Further average particle size and PDI were measured to determine whether centrifugation had an effect on this. If the results are as shown in Table 3:

[0123] Table 3. Changes in particle size and PDI of cinnamaldehyde nanoemulsion before and after centrifugation under different centrifugal speed conditions

[0124]

[0125] Multiple comparisons were made on the data in the above table, and p>0.05 was found among the groups with different centrifugal speeds, indicating that different centrifugal speeds had no significant effect on the particle size and stability of cinnamaldehyde nanoemulsion.

[0126] 4.2 Dilution stability

[0127] The cinnamaldehyde nanoemulsion described in Example 1 was divided into three equal parts, and diluted with distilled water 10, 100, and 1000 times, respectively, to observe the apparent changes of the cinnamaldehyde nanoemulsion before and after dilution. The results showed that after dilution according to the above multiples, the cinnamaldehyde nanoemulsion was still clear and transparent, and no unstable phenomena such as stratification, demulsification, and precipitation occurred, indicating that the dilution stability was good.

[0128] 4.3 pH stability

[0129] pH stability

[0130] Grouping:

[0131] pH 4.00 group: The cinnamaldehyde self-emulsifying nanoemulsion in this group differs from that in Example 1 only in that a phosphate buffer solution with a pH of 4.00 is used instead of distilled water, and the rest is the same as in Example 1.

[0132] pH 6.86 group: The cinnamaldehyde self-emulsifying nanoemulsion in this group differs from that in Example 1 only in that a phosphate buffer solution with a pH of 6.86 is used instead of distilled water, and the rest is the same as in Example 1.

[0133] pH 9.18 group: The cinnamaldehyde self-emulsifying nanoemulsion in this group differs from that in Example 1 only in that a phosphate buffer solution with a pH of 9.18 is used instead of distilled water, and the rest is the same as in Example 1.

[0134] Control group: cinnamaldehyde self-emulsifying nanoemulsion prepared in Example 1.

[0135] After the four groups were prepared, they were placed indoors at room temperature and away from light for 24 hours to observe the visual changes of the cinnamaldehyde nanoemulsions and to measure the average particle size and PDI of the cinnamaldehyde nanoemulsions at different pH values.

[0136] like Figure 8 As shown, the results of ANOVA analysis of particle size determination showed that there was no significant difference in particle size between pH = 6.86 and pH = 7.00, indicating that the stability of cinnamaldehyde nanoemulsion was good within this pH range.

[0137] 4.4 Placement stability

[0138] The cinnamaldehyde nanoemulsion prepared in Example 1 was divided into two groups. One group was stored in an environment of -20°C, 4°C, 25°C, and 60°C for 1 month, and the other group was placed in an environment of shading and illumination at room temperature to observe whether the cinnamaldehyde nanoemulsion had any apparent changes and to measure the average particle size and PDI. Fig. 9 , 10 As shown, the test results found that there was no significant difference in stability between the temperatures of 4°C and 25°C. No additional steps are required in the production and storage of the preparation, the storage requirements are low, and it can be placed at room temperature.

[0139] Comparative Example 1

[0140] This comparative example provides a cinnamaldehyde self-emulsifying nanoemulsion. The difference between this comparative example and Example 1 is that Tween 80 is used instead of EL-40, and the rest is the same as Example 1.

[0141] Comparative Example 2

[0142] This comparative example provides a cinnamaldehyde self-emulsifying nanoemulsion. The difference between this comparative example and Example 1 is that the amount of cinnamaldehyde is 0.32 g, and the rest is the same as Example 1.

[0143] Comparative Example 3

[0144] This comparative example provides a cinnamaldehyde self-emulsifying nanoemulsion. The difference between this comparative example and Example 1 is only that the amount of ethanol used is 1 g, and the rest is the same as Example 1.

[0145] The in vitro antibacterial and anti-MRSA biofilm properties of the cinnamaldehyde self-emulsifying nanoemulsions prepared in Examples 1-2 and Comparative Examples 1-3 were measured:

[0146] Drugs and reagents

[0147] Enterococcus faecalis, drug-resistant Salmonella (SJ2), Escherichia coli, Salmonella enteritidis, Pasteurellaceae, Pseudomonas aeruginosa, all of the above strains were isolated, identified, cultured and preserved by the College of Veterinary Medicine of Sichuan Agricultural University, all of them are existing strains, and can also be obtained commercially. Salmonella pullorum and methicillin-resistant Staphylococcus aureus (MRSA) were purchased from American type culture collection (ATCC).

[0148] Trial Groups:

[0149] Example 1 group: the cinnamaldehyde nanoemulsion prepared in Example 1 was used, and the concentration of cinnamaldehyde was adjusted to 1024 μg / mL using PBS buffer solution;

[0150] Example 2 group: the cinnamaldehyde nanoemulsion prepared in Example 2 was used, and the concentration of cinnamaldehyde was adjusted to 1024 μg / mL using PBS buffer solution;

[0151] Comparative Example 1: The cinnamaldehyde nanoemulsion prepared in Comparative Example 1 was used, and the concentration of cinnamaldehyde was adjusted to 1024 μg / mL using PBS buffer solution;

[0152] Comparative Example 2: The cinnamaldehyde nanoemulsion prepared in Comparative Example 2 was used, and the concentration of cinnamaldehyde was adjusted to 1024 μg / mL using PBS buffer solution;

[0153] Comparative Example 3 group: the cinnamaldehyde nanoemulsion prepared in Comparative Example 3 was used, and the concentration of cinnamaldehyde was adjusted to 1024 μg / mL using PBS buffer solution;

[0154] PBS group: Phosphate buffered saline (PBS) with a pH of 7.3 was used.

[0155] Cinnamaldehyde group: The concentration of cinnamaldehyde was 1024 μg / mL, and the pH value was 7.2±0.2.

[0156] 1. Activation and cultivation of experimental strains

[0157] In the clean bench, the stored methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, clinical bacteria of Salmonella enteritidis S1, Enterococcus faecalis, drug-resistant Salmonella (SJ2), Pasteurellaceae, Pseudomonas aeruginosa, and Salmonella pullorum were activated on TSB medium at a ratio of 1 μL bacterial solution to 100 mL culture medium, and cultured in a 37°C constant temperature microbiological incubator for 24 hours. Then, they were inoculated into TSB medium at a ratio of 1 μL bacterial solution to 100 mL culture medium, placed in a 37°C constant temperature shaker at 100 rpm / min and cultured to the logarithmic growth phase, and placed in a 4°C refrigerator for use.

[0158] 2. Determination of MIC and MBC

[0159] According to the standards of the American Clinical Laboratory Standards Institute (CLSI), the minimum inhibitory concentration (MIC) of cinnamaldehyde and cinnamaldehyde self-emulsifying nanoemulsion was determined by microdilution method, and the minimum bactericidal concentration (MBC) was determined by plate colony counting method. A single colony of the test strain was picked in 200 mL of TSB liquid culture medium and cultured overnight at 37 ° C in a constant temperature oscillator for 12 h. The bacterial solution concentration was adjusted to 1 × 10 6CFU / mL, take the bacterial solution and add it to a 96-well plate, add 10 μL of bacterial solution to each well, add cinnamaldehyde of different concentrations diluted in multiples, and the cinnamaldehyde nanoemulsion prepared in Example 1, and the multiple dilution concentrations are 2048 μg / mL, 1024 μg / mL, 512 μg / mL, 256 μg / mL, 128 μg / mL, and 64 μg / mL, respectively. Incubate in a 37°C constant temperature incubator for 24 hours, observe by resazurin staining, and the lowest drug concentration well with blue (sterile growth) on the well plate is the MIC value of the tested bacteria. Take 100 μL from the sterile growth well and apply it to the TSA solid plate. After culturing for 24 hours, count the colonies. The number of colonies does not exceed 5, which is the MBC of the system for the strain.

[0160] 3. Crystal violet staining method to determine the clearance effect of cinnamaldehyde nanoemulsion on MRSA biofilm

[0161] The MRSA bacterial solution cultured overnight and the BHI medium with a mass concentration of 3% sucrose were added to a 24-well plate in a volume ratio of 1:10, and the MRSA biofilm was formed by constant temperature static culture at 37°C for 24 hours. After the biofilm is formed, the culture medium is gently aspirated, and the plates are washed three times with PBS, and then added to Example 1-2 group, Comparative Example 1-3 group, PBS group and cinnamaldehyde group respectively. The plates are kept statically cultured at 37°C for 12 hours, the culture medium is discarded, and the plates are rinsed three times with sterile PBS. After drying, 200 μL of 99% methanol is added to fix the plates for 30 minutes and then discarded. 200 μL of 0.1% crystal violet is added to stain the plates for 30 minutes, and then the plates are discarded and rinsed. After drying, 200L of 33% glacial acetic acid is added to dissolve the plates for 30 minutes. Finally, OD600 is measured with an enzyme reader, and the biofilm clearance rate is calculated by absorbance. Three parallel plates are set up for each group, and the results are as follows Fig.13 , 14 shown.

[0162] 4. Laser confocal microscopy observation of cinnamaldehyde nanoemulsion killing bacteria in biofilm

[0163] SYTO 9 dye is a green fluorescent counterstain for live bacteria, while PI is a red fluorescent dye that can only stain dead bacteria. After culturing the biofilm in the same experimental method as above, the biofilm was washed three times with PBS, and the Example 1-2 group, the Comparative Example 1-3 group, the PBS group and the cinnamaldehyde group were added. After incubation at 37°C for 12 hours, the liquid was removed, and SYTO 9 dye was added for staining for 1 hour, washed three times with PBS, and then PI dye was added for staining for 30 minutes, washed three times, and the killing of bacteria in the biofilm by different treatment groups was observed by 3D imaging of laser confocal microscopy.

[0164] 5. SEM imaging

[0165] The biofilm was cultured in the same manner as the above experimental method. After the biofilm matured, it was washed three times with PBS, and the Example 1-2 group, the Comparative Example 1-3 group, the PBS group and the cinnamaldehyde group were added respectively. After incubation at 37° C. for 12 h, the liquid was removed, and a 2.5% glutaraldehyde electron microscopy fixative was added to fix the biofilm overnight, and then the biofilm was gradient dehydrated, critical point dried, and gold-plated, and observed using a field emission scanning electron microscope.

[0166] 6. Results: In vitro antibacterial properties of cinnamaldehyde nanoemulsions

[0167] 6.1 Determination of MIC and MBC

[0168] GraphPad Prism 10.0.2 software was used to perform paired sample T-test analysis on the obtained MIC and MBC results, and a two-dimensional group comparison graph was made. Fig.11 , 12 As shown, the results show that, except for Escherichia coli, the in vitro antibacterial activity of the cinnamaldehyde nanoemulsion prepared in Example 1 is better than that of the cinnamaldehyde original drug. It has a more significant antibacterial and bactericidal effect on drug-resistant Salmonella (SJ2) and clinical bacteria S1 (Salmonella enteritidis).

[0169] 6.2 Determination of the effectiveness of nanoemulsion in clearing MRSA biofilm

[0170] like Fig.13 , 14 As shown, the results show that the cinnamaldehyde nanoemulsions prepared in Examples 1-2 have a good removal effect on MRSA biofilm, among which Example 1 has the highest removal rate, reaching 76.3%. Although Example 2 has a slight decrease, the removal rate also reaches 68%.

[0171] Cinnamaldehyde had a poor effect on the removal of MRSA biofilm, with a removal rate of only 24.1%.

[0172] In the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 1, Tween 80 was used instead of EL-40. The emulsification ability of Tween 80 was lower than that of EL-40, which resulted in a significant decrease in the clearance rate, which could only reach 51%.

[0173] The cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 2 has a poor effect on removing MRSA biofilm due to the small amount of cinnamaldehyde used. Therefore, the removal rate is greatly reduced to only 42%.

[0174] In the cinnamaldehyde self-emulsifying nanoemulsion prepared in Comparative Example 3, the emulsifying effect of the nanoemulsion was reduced due to the small amount of ethanol used. Therefore, the clearance rate was greatly reduced to only 56%.

[0175] 6.3 Laser confocal microscopy observation of the killing effect of cinnamaldehyde nanoemulsion on bacteria on MRSA biofilm

[0176] Live bacteria will be stained with SYTO9 dye to show green fluorescence, while dead bacteria will be stained with PI dye to show red fluorescence. Fig.15 As shown, the biofilms in the PBS treatment group are almost all green fluorescent and have a dense structure, indicating that the content of live bacteria in the biofilm is extremely high. The biofilms in the cinnamaldehyde treatment group have red fluorescence but the green fluorescence accounts for the majority, indicating that cinnamaldehyde can only kill a small number of live bacteria on the biofilm, and most of them still exist in the form of live bacteria. The cinnamaldehyde nanoemulsions prepared in Examples 1-2 have a red fluorescence that accounts for the majority, and only a small amount of green fluorescence can be seen. Among them, Example 1 has the best effect, and almost no green fluorescence can be seen. This shows that the cinnamaldehyde nanoemulsion has a strong effect on killing live bacteria on MRSA biofilms. The killing effect of the cinnamaldehyde nanoemulsion prepared in Comparative Example 1 on MRSA biofilm is not as good as that in Example 1, indicating that the use of EL-40 as an emulsifier is more advantageous; although the cinnamaldehyde nanoemulsion prepared in Comparative Example 2 has a killing effect on the biofilm, it does not kill all the live bacteria on the biofilm, indicating that when the amount of cinnamaldehyde added is low, the drug loading of the nanoemulsion is low and the effect is not good; the killing effect of the cinnamaldehyde nanoemulsion prepared in Comparative Example 3 on MRSA biofilm is not as good as that in Example 1, indicating that a decrease in ethanol content will lead to a decrease in the emulsification ability of the nanoemulsion.

[0177] 6.4 Scanning electron microscopy observation of drug removal effect on mature biofilm

[0178] like Fig.16 As shown, the scanning electron microscopy results show that the biofilm structure of the PBS control group is dense, and the density of the membrane structure is reduced to a certain extent after cinnamaldehyde treatment. After treatment with the cinnamaldehyde nanoemulsion prepared in Examples 1-2, the bacterial morphology is wrinkled and the bacteria are sparse, among which Example 1 has the best effect, and the membrane structure has basically disappeared. After treatment with the cinnamaldehyde nanoemulsion prepared in Comparative Example 1, the bacterial morphology is partially wrinkled, and the membrane structure is loose, but the membrane structure is still visible; after treatment with the cinnamaldehyde nanoemulsion prepared in Comparative Example 2, the bacterial morphology is partially wrinkled, and there is still a membrane structure; after treatment with the cinnamaldehyde nanoemulsion prepared in Comparative Example 3, the bacterial morphology is partially wrinkled, and there is still a partial membrane structure.

[0179] The experimental results show that the particle size of the cinnamaldehyde nanoemulsion of the present invention is small, which is conducive to the entry of cinnamaldehyde into bacterial cells to exert pharmacological effects. At the same time, the stability difference is not significant under the environment of pH=6.86, pH=7.00 and temperature of 4°C and 25°C. No additional steps are required during the production and storage of the preparation, and the storage requirements are low, and it can be placed at room temperature. At the same time, the dilution multiple does not affect the stability of the cinnamaldehyde nanoemulsion, which is beneficial to the production practices such as aquaculture, livestock and poultry breeding.

[0180] In vitro antibacterial studies have confirmed that cinnamaldehyde nanoemulsion has a stronger inhibitory effect on most Gram-negative and Gram-positive bacteria than cinnamaldehyde original drug, and has a more significant inhibitory and bactericidal effect on clinical bacteria such as drug-resistant Salmonella (SJ2) and clinical Salmonella enteritidis S1 (Salmonella enteritidis) compared with the original drug. Crystal violet staining, laser confocal microscopy, and scanning electron microscopy results show that cinnamaldehyde nanoemulsion has a better bactericidal effect on the removal of MRSA biofilm than cinnamaldehyde.

[0181] The embodiments of the present application are described above in conjunction with the accompanying drawings, but the present application is not limited to the above-mentioned specific implementation methods. The above-mentioned specific implementation methods are merely illustrative and not restrictive. Under the guidance of the present application, ordinary technicians in this field can also make many forms without departing from the purpose of the present application and the scope of protection of the claims, all of which are within the protection of the present application.

Claims

1. A cinnamaldehyde self-emulsifying nanoemulsion, characterized in that: The nanoemulsion is composed of: 5-10% oil phase, 30-40% emulsifier, 15-20% co-emulsifier, 5-10% cinnamaldehyde and 20-40% distilled water in weight percentage.

2. A cinnamaldehyde self-emulsifying nanoemulsion according to claim 1, characterized in that: The oil phase is ethyl acetate, the emulsifier is EL-40, and the co-emulsifier is ethanol.

3. A cinnamaldehyde self-emulsifying nanoemulsion according to claim 2, characterized in that: The nanoemulsion is composed of 9.34% ethyl acetate, 39.13% EL-40, 18.2% ethanol, 5% cinnamaldehyde and 28.33% distilled water in weight percentage.

4. The cinnamaldehyde self-emulsifying nanoemulsion according to claim 1, characterized in that: The nanoemulsion is an O / W nanoemulsion.

5. The cinnamaldehyde self-emulsifying nanoemulsion according to claim 1, characterized in that: The average particle size of the nanoemulsion is (14.29±0.16) nm, and the PDI is 0.068±0.

003.

6. A method for preparing a cinnamaldehyde self-emulsifying nanoemulsion according to any one of claims 1 to 5, characterized in that: The following steps are involved: The oil phase and cinnamaldehyde are put into a stirring device at room temperature, stirred and mixed with a magnetic stirrer to form a uniform system, and then the emulsifier and the co-emulsifier are added in sequence and stirred on the magnetic stirrer. After the system is evenly mixed, the distilled water is added dropwise while stirring to form a nanoemulsion, and finally a transparent and uniform yellow cinnamaldehyde nanoemulsion system is presented.

7. Use of a cinnamaldehyde self-emulsifying nanoemulsion according to any one of claims 1 to 5 in preparing a drug for removing MRSA biofilm.

8. A drug for removing MRSA biofilm, characterized in that: The invention comprises the cinnamaldehyde self-emulsifying nanoemulsion according to any one of claims 1 to 5.

9. The drug for removing MRSA biofilm according to claim 8, characterized in that: The medicine also includes other pharmaceutically acceptable carriers or excipients.

Citation Information

Cited By

  • Antibacterial emulsion as well as preparation method and application thereof

    CN119453198A

  • Preparation method and application of 2, 4-di-tert-butylphenol nanoemulsion

    CN121336800A